{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:20:40Z","timestamp":1741238440385,"version":"3.38.0"},"reference-count":37,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.nephro.2009.12.004","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T10:55:40Z","timestamp":1267095340000},"page":"105-110","source":"Crossref","is-referenced-by-count":8,"title":["Traitement de l\u2019hyperparathyro\u00efdie secondaire, r\u00e9sistante aux th\u00e9rapeutiques conventionnelles, et de l\u2019hyperparathyro\u00efdie tertiaire par le cinacalcet\u00a0: une strat\u00e9gie efficace"],"prefix":"10.1684","volume":"6","author":[{"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Vanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Terrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Hurot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie","family":"Lorriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Deleaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Vovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2009.12.004_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.12.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1523-1755.2000.00183.x","article-title":"A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism","volume":"58","author":"Goodman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent amg 073\u00a0lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2006.01.015","article-title":"Meta-analysis of biochemical and patient-level effects of calcimimetic therapy","volume":"47","author":"Strippoli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving nkf-k\/doqi bone metabolism and disease treatment goals with cinacalcet HCL","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.12.004_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2215\/CJN.04520908","article-title":"Treatment of secondary hyperparathyroidism in ckd patients with cinacalcet and\/or vitamin D derivatives","volume":"4","author":"Drueke","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The optima study: assessing a new cinacalcet (sensipar\/mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet hcl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 5:","key":"10.1016\/j.nephro.2009.12.004_bib11","doi-asserted-by":"crossref","first-page":"V27","DOI":"10.1093\/ndt\/gfh1053","article-title":"Clinical experience with cinacalcet HCL","volume":"19","author":"Urena Torres P","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfh829","article-title":"Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism","volume":"20","author":"Lien","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib14","first-page":"S1","article-title":"Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"KDIGO","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004\u00a0through 2006","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfp144","article-title":"Cinacalcet and achievement of the nkf\/k-doqitm recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study","author":"Urena","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib17","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet hcl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1523-1755.2005.310_1.x","article-title":"High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism","volume":"67","author":"Touam","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.12.004_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP68010","article-title":"Cinacalcet HCL (sensipar\/mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism","volume":"68","author":"Sterrett","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib20","article-title":"Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism","author":"Yano","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.nephro.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/CNP70126","article-title":"Efficacy of cinacalcet administered with the first meal after dialysis: the Sensor study","volume":"70","author":"Schaefer","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCL effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP68063","article-title":"Twelve months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers","volume":"68","author":"Jean","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfm172","article-title":"Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism","volume":"22","author":"Jean","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","article-title":"Differences in vitamin D status between countries in young adults and the elderly","volume":"93","author":"McKenna","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2009.12.004_bib28","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00467-008-0842-x","article-title":"Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease","volume":"23","author":"Menon","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2009.12.004_bib29","first-page":"21","article-title":"Vitamin D and fracture reduction: an evaluation of the existing research","volume":"13","author":"Brown","year":"2008","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.nephro.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.annepidem.2008.03.007","article-title":"Vitamin D and intervention trials in prostate cancer: from theory to therapy","volume":"19","author":"Schwartz","year":"2009","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.nephro.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11914-009-0011-6","article-title":"Vitamin D and immune function: understanding common pathways","volume":"7","author":"Bikle","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.nephro.2009.12.004_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-008-9115-5","article-title":"Vitamin D and diabetes mellitus","volume":"35","author":"Danescu","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.nephro.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MNH.0b013e3282ff64a3","article-title":"Vitamin D and the immune system: role in protection against bacterial infection","volume":"17","author":"Bikle","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nephro.2009.12.004_bib34","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","article-title":"Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography","volume":"93","author":"Pilz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2009.12.004_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.12.004_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfp370","article-title":"Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.12.004_bib37","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000151534","article-title":"Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6\u00a0months of 25-hydroxycholecalciferol treatment","volume":"110","author":"Jean","year":"2008","journal-title":"Nephron Clin Pract"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2009.12.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:43:00Z","timestamp":1741185780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725510000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1769725510000052"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2009.12.004","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}